12:00 AM
Jun 24, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

KaloBios management update

KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), South San Francisco, Calif.
Business: Antibodies,...

Read the full 28 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >